4-Bromo-6-methyl-1,6-dihydro-7H-pyrrolo[2,3-c]pyridin-7-one, 95%, 500mg

Ethyl 2-amino-6-methyl-4,5,6,7-tetrahydrothieno-[2,3-c]pyridine-3-carboxylate, 95.0%, 10g

3-((2,2,10,10-Tetramethyl-4,8-dioxo-3,9-dioxa-5,7-diazaundecan-6-ylidene)amino)propanoic acid, 97%, 1g

(3-Amino-5-methoxybenzofuran-2-yl)-(4-fluoro-phenyl)-methanone, 97%, 1g

Neissers solution II, 100 ml

1-Hexyl-3-methylimidazolium tetrafluoroborate, 97.0%, 10g

CPhos, 98%, 10g

Activated carbon, 4 mm, impregnated with phosphoric acid, 1 kg, plastic packaging.

Ethyl 2-Bromopropionate>98.0%(GC)25g

2-Hydroxy-4,6-dimethylpyridine-3-carbothioamide, 95.0%, 10g

1-(2-(Trifluoromethyl)phenyl)ethanamine, 95.0%, 250mg

(R)-tert-Butyl 2-((7-chloropyrido[4,3-b]pyrazin-5-ylamino)methyl)morpholine-4-carboxylate, 97.0%, 100mg

2-Methyl-5-(4-trifluoromethoxy-phenyl)-furan-3-carboxylic acid amide, 95.0%, 1g